Protara Therapeutics Inc
NASDAQ:TARA

Watchlist Manager
Protara Therapeutics Inc Logo
Protara Therapeutics Inc
NASDAQ:TARA
Watchlist
Price: 5.25 USD -2.05% Market Closed
Market Cap: 202.6m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of TARA.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TARA Intrinsic Value
Not Available
Base Case Scenario
Compare TARA to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TARA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Protara Therapeutics Inc

Current Assets 135.6m
Cash & Short-Term Investments 132.7m
Receivables 1m
Other Current Assets 2m
Non-Current Assets 9m
Long-Term Investments 957k
PP&E 4.3m
Other Non-Current Assets 3.8m
Current Liabilities 9.9m
Accounts Payable 4.5m
Accrued Liabilities 5.4m
Non-Current Liabilities 2.4m
Other Non-Current Liabilities 2.4m
Efficiency

Free Cash Flow Analysis
Protara Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Protara Therapeutics Inc

Revenue
0 USD
Operating Expenses
-59.8m USD
Operating Income
-59.8m USD
Other Expenses
6.9m USD
Net Income
-52.9m USD
Fundamental Scores

TARA Profitability Score
Profitability Due Diligence

Protara Therapeutics Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
23/100
Profitability
Score

Protara Therapeutics Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

TARA Solvency Score
Solvency Due Diligence

Protara Therapeutics Inc's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
High Altman Z-Score
76/100
Solvency
Score

Protara Therapeutics Inc's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TARA Price Targets Summary
Protara Therapeutics Inc

Wall Street analysts forecast TARA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TARA is 25.5 USD with a low forecast of 21.21 USD and a high forecast of 31.5 USD.

Lowest
Price Target
21.21 USD
304% Upside
Average
Price Target
25.5 USD
386% Upside
Highest
Price Target
31.5 USD
500% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Protara Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TARA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

TARA Insider Trading
Buy and sell transactions by insiders